What JUVEN Is and How It Can Help

Juven® is a therapeutic nutrition drink designed to help fight loss of lean body mass in people with cancer. Juven contains a unique blend of three key ingredients — HMB, arginine and glutamine. You can find these three natural components in a healthy body.

• HMB (β-hydroxy-β-methylbutyrate) helps build lean body mass and protects cell strength and structure.
• Arginine is an amino acid (building block of protein) key for building lean body mass and for immune cell development.
• Glutamine is an amino acid (building block of protein) key for building lean body mass and fueling immune cells and gastrointestinal (GI) cells.

By working together, these three ingredients help counteract changes caused by cancer that lead to weight and muscle loss. The blend of all these important nutrients makes Juven effective for adding muscle to your fight against cancer.

A clinical study among people with cancer showed that drinking Juven daily as part of overall care for a four-week period helped build muscle. Muscle is important to help you feel strong and remain active and independent.

Drinking Juven — twice a day — also supplies these additional benefits for those living with cancer:

• Helps build lean body mass without fat gain1,2
• Provides only 1g of sugar per serving (orange flavor)
• Supports healing3
• Offers an excellent source of calcium

Start Drinking Juven Early

The earlier you start Juven, the easier it may be to manage, or even hold off, your weight and muscle loss. A loss of as little as 5 percent of your body weight may reduce your ability to continue your cancer treatment. Slowing your weight loss and building and maintaining lean body mass can give you more energy for the independence and activities you treasure.

You may see results in as little as four weeks by adding just two servings a day to your regular diet.

Talk with your health care professional to see if Juven is right for you.

Juven Brochure (0.5MB)

References

1. Clark RH, Feleke G, Din M, et al: Nutritional treatment for acquired immunodeficiency virus-associated wasting using β-hydroxy-β-methylbutyrate, glutamine, and arginine: A randomized, double-blind placebo-controlled study. JPEN 2000;24:133-139.
2. Wheeler DA, Gibert CL, Launer CA, et al: J Acquir Immune Defic Syndr Hum Retrovirol 1998;18:80-85.
3. Macallan DC: Proc Nutr Soc 1999;58:743-748.